Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Interventional × Noonan Syndrome × Clear all

Phase

Phase 1 7 Phase 1/2 3 Phase NA 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2330 Carcinoma, Non-Small-Cell Lung 1895 Prostatic Neoplasms 1226 Colorectal Neoplasms 1075 Neoplasms 1043 Multiple Myeloma 908 Lung Neoplasms 870 Neoplasm Metastasis 850 Leukemia, Myeloid, Acute 825 Lymphoma 752 Melanoma 737 Pancreatic Neoplasms 697 Ovarian Neoplasms 679 Carcinoma, Hepatocellular 649 Recurrence 645 Stomach Neoplasms 640 Leukemia 630 Lymphoma, Non-Hodgkin 572 Leukemia, Lymphocytic, Chronic, B-Cell 553 Lymphoma, Large B-Cell, Diffuse 526 Squamous Cell Carcinoma of Head and Neck 519 Precursor Cell Lymphoblastic Leukemia-Lymphoma 504 Head and Neck Neoplasms 503 Brain Neoplasms 502 Glioblastoma 494 Carcinoma, Renal Cell 485 Rectal Neoplasms 480 Myelodysplastic Syndromes 442 Sarcoma 432 Lymphoma, Follicular 432

Interventions

Lovastatin 1 Lamotrigine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03504501 2023-11-30

SynCoRAS

Technical University of Munich

Phase 2 Terminated

Cognition Disorders, Neurofibromatosis 1, Noonan Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡